Amphetamine Stimulant Prodrug denied for missing prior authorization by Humana?

Humana's specific coverage criteria for amphetamine stimulant prodrug are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Requires Prior Authorization for This Drug

Humana requires prior authorization (PA) for amphetamine-class stimulant prodrugs as part of its utilization-management program for controlled substances. A PA denial means either that authorization was not obtained before dispensing, or that a PA request was submitted and Humana determined the submitted documentation did not satisfy the clinical criteria in its coverage policy. This is one of the most commonly issued — and most commonly reversed — denial types for stimulant medications.

## Your Appeal Rights

PA denials are fully appealable. ACA §2719 guarantees the right to an internal appeal followed by independent external review for plans subject to the ACA. ERISA §503 provides equivalent protections for most employer-sponsored plans. The external-review window is generally open for approximately four months after a final internal denial. If your health condition creates urgency, you may request the expedited review track — a decision is required within 72 hours.

## Appeal Process and Timeline

1. Request the denial letter specifying which PA criteria were not met and which clinical policy was applied. 2. Contact your prescriber immediately — PA appeals require the prescriber to lead or co-sign the submission because the missing documentation typically must come from the treating provider's records. 3. File the internal appeal within Humana's deadline (typically 60 days from denial). Humana must respond within 30 days (pre-service) or 60 days (post-service). 4. If denied internally, request external review through Humana or your state insurance commissioner. 5. For urgent situations, request expedited external review — a 72-hour decision is required.

## Documentation to Gather

• Diagnosis documentation: Current office notes with a formally documented diagnosis — including symptom presentation, severity, and functional impact — that meets the qualifying condition in Humana's PA policy.
• Prior treatment history: A dated, itemized list of other treatments previously tried for this condition, including duration, dose range, and documented reason for discontinuation or inadequate response.
• Clinical severity evidence: Chart notes quantifying the impact of the condition on daily functioning, work or academic performance, or safety.
• Prescriber medical-necessity letter: Addresses each PA criterion from Humana's policy, explains why this drug is the appropriate choice, and attests that the patient meets the coverage requirements.
• Humana's PA criteria: Download the current prior-authorization requirements from Humana's provider portal or request them directly. Map every criterion.

## Criteria-Mapping Structure

Create a two-column table: each PA criterion from Humana's policy in the left column; the exact chart evidence satisfying it in the right — including note date, document type, and the specific finding. This structure prevents the reviewer from issuing a generic denial and, on external review, demonstrates that every criterion was addressed with specific clinical evidence rather than general assertions.